BCE Inc.
BCE Inc. (BCEPF) Financial Performance & Income Statement Overview
Analyze BCE Inc. (BCEPF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
BCE Inc. (BCEPF) Income Statement & Financial Overview
View the income breakdown for BCE Inc. BCEPF across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.93B | $6.42B | $5.97B | $6.005B |
| Cost of Revenue | $1.89B | $2.29B | $1.74B | $4.12B |
| Gross Profit | $4.04B | $4.13B | $4.24B | $1.89B |
| Gross Profit Ratio | $0.68 | $0.64 | $0.71 | $0.31 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.00B | $1.03B | $1.03B | $1.04B |
| Operating Expenses | $2.75B | $2.78B | $2.77B | $460.00M |
| Total Costs & Expenses | $4.64B | $5.07B | $4.51B | $4.58B |
| Interest Income | $51.00M | $56.00M | $60.00M | $42.00M |
| Interest Expense | $423.00M | $439.00M | $449.00M | $426.00M |
| Depreciation & Amortization | $1.27B | $1.25B | $1.26B | $1.27B |
| EBITDA | $2.63B | $2.35B | $688.00M | $2.71B |
| EBITDA Ratio | $0.44 | $0.37 | $0.12 | $0.45 |
| Operating Income | $1.29B | $1.35B | $1.46B | $2.71B |
| Operating Income Ratio | $0.22 | $0.21 | $0.25 | $0.45 |
| Other Income/Expenses (Net) | -$346.00M | -$675.00M | -$2.65B | -$1.88B |
| Income Before Tax | $940.00M | $680.00M | -$1.19B | $835.00M |
| Income Before Tax Ratio | $0.16 | $0.11 | -$0.20 | $0.14 |
| Income Tax Expense | $257.00M | $175.00M | $5.00M | $231.00M |
| Net Income | $671.00M | $504.00M | -$1.19B | $583.00M |
| Net Income Ratio | $0.11 | $0.08 | -$0.20 | $0.10 |
| EPS | $0.68 | $0.51 | -$1.36 | $0.59 |
| Diluted EPS | $0.68 | $0.51 | -$1.36 | $0.59 |
| Weighted Avg Shares Outstanding | $920.30M | $912.30M | $912.30M | $912.30M |
| Weighted Avg Shares Outstanding (Diluted) | $920.30M | $912.30M | $912.30M | $912.30M |
The company's financials show resilient growth, with revenue advancing from $6.005B in Q2 2024 to $5.93B in Q1 2025. Gross profit remained healthy with margins at 68% in Q1 2025 compared to 31% in Q2 2024. Operating income hit $1.29B last quarter, sustaining a consistent 22% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.63B. Net income rose to $671.00M, while earnings per share reached $0.68. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan